MedTrace Logo

Study to Evaluate the Effects of Psyllium on Blood Glucose

NCT00888602 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2012-12-20

No results posted yet for this study

Summary

This is an open label, single use, randomized, 4-period cross-over study. In each period, subjects will receive one of 4 test combinations. Blood will be drawn prior to study product consumption and following study product consumption for glucose measures.

Conditions

  • Healthy Men

Interventions

DIETARY_SUPPLEMENT

3.4 g psyllium

3.4 g psyllium served with meal

DIETARY_SUPPLEMENT

6.8 g psyllium

6.8 g psyllium served with a meal

DIETARY_SUPPLEMENT

6.8 g psyllium

6.8 g psyllium

OTHER

Meal

meal

Sponsors & Collaborators

  • Procter and Gamble

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2009-05-31
Completion
2009-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00888602 on ClinicalTrials.gov